Is Omnipod 5 cost effective for the management of type 1 diabetes among adults in France?

Diabetes and Metabolism · Published 2025-12-16 · DOI 10.1016/j.diabet.2025.101721

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.diabet.2025.101721

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Economic Burden of Type 1 Diabetes in France · Diabetes, Obesity and Metabolism · 2026 · Cites or is cited by this article
• A clinical prediction model for beta cell monogenetic diabetes in Chinese patients with early-onset type 2 diabetes · Diabetes and Metabolism · 2026 · Same journal
• No association between carbohydrate-counting knowledge and disordered eating behaviors in adults with type 1 diabetes · Diabetes and Metabolism · 2026 · Same journal
• "Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis · Diabetes and Metabolism · 2025 · Same journal
• Telemedicine-based diabetic retinopathy screening in patients over 70 Years: a French cohort study within the OPHDIAT network · Diabetes and Metabolism · 2026 · Same journal
• Comparative effectiveness of sodium–glucose cotransporter-2 versus dipeptidyl peptidase-4 inhibitors on all-cause mortality in type 2 diabetes: a multinational propensity score–matched cohort study · Diabetes and Metabolism · 2026 · Same journal
• Impact of high intensity physical activity compared to routine counseling on renal function decline in patients with type 2 diabetes at high risk for kidney disease - the ACTIDIANE randomized controlled trial · Diabetes and Metabolism · 2026 · Same journal
• Pancreatic polypeptide in patients with type 1 diabetes and exocrine failure or chronic pancreatitis. The DIAPP study · Diabetes and Metabolism · 2025 · Same journal
• Ulcer topography matters: hindfoot versus forefoot outcomes in first-time diabetic foot ulcer · Diabetes and Metabolism · 2025 · Same journal
• Comparative cardiovascular effectiveness of GLP-1RAs versus DPP-4is in dialysis patients with type 2 diabetes: a target trial emulation · Diabetes and Metabolism · 2026 · Same journal